Aptevo Therapeutics (APVO) Total Debt Growth (1y) (2016 - 2022)
Aptevo Therapeutics (APVO) Total Debt Growth (1y) (2016 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.10% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 12.42% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -57.72% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 3.78% |
| 10 | Aptevo Therapeutics | 3.18 Mn | -6.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -77.52% |
| Sep 30, 2022 | -74.24% |
| Jun 30, 2022 | -70.92% |
| Mar 31, 2022 | -67.50% |
| Dec 31, 2021 | -38.64% |
| Sep 30, 2021 | -39.76% |
| Dec 31, 2020 | 26.13% |
| Sep 30, 2020 | 27.87% |
| Dec 31, 2019 | 3.03% |
| Sep 30, 2019 | 2.95% |
| Jun 30, 2019 | -0.05% |
| Mar 31, 2019 | 0.55% |
| Dec 31, 2018 | 1.14% |
| Sep 30, 2018 | 9.49% |
| Jun 30, 2018 | 4.39% |
| Mar 31, 2018 | 4.74% |
| Dec 31, 2017 | 3.69% |
| Sep 30, 2017 | -4.43% |
| Jun 30, 2017 | 9,714.14% |
| Dec 31, 2016 | 4,040.32% |